NASDAQ

Tempest Therapeutics, Inc. (TPST)

♥ 656 Thanks from members

Live price chart, market sentiment, and community perspectives for Tempest Therapeutics, Inc. (NASDAQ: TPST).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: Tempest Therapeutics Science TeamLeadership: Stephen Brady (CEO)Leadership: Tom Dubensky (CSO)Holder: Fidelity Management and ResearchHolder: Versant VenturesHolder: New Enterprise AssociatesAmcenestrantTPST-1120TPST-1495#TPST#Tempest Therapeutics#NASDAQ TPST#oncology biotech#cancer immunotherapy